Dr Nabila Bouatia-Naji obtained her PhD on Human genetics in 2006 from the University of Lille, France. After a postdoctoral fellowship at the Medical Research Council, Cambridge University, UK, she was recruited as an INSERM research associate in 2009. Since 2011, she works at the Paris Cardiovascular research center (PARCC), an INSERM and Universite Sorbonne Paris Cite affiliated research center. She is the director of an ERC Starting Grant supported team (2017-2022) and an INSERM labelled (Team3) at the PARCC-INSERM (Since 2018). Her research is dedicated to study the genetic etiology of cardiometabolic diseases and has widely contributed to the identification of numerous genetics risk factors through genome-wide association studies and functional genomics. After a solid publication track on the genetics of diabetes related traits, she focused her research on the study of fibromuscular dysplasia that causes hypertension and predisposes to stroke and spontaneous coronary artery dissection, an emerging form of acute myocardial infarction predominantly afflicting women. She uses cutting edge genomic technology and multidisciplinary approaches in wet and dry lab experimentation to address the genetic predisposition to these women specific arterial diseases. Dr Bouatia-Naji is a well-recognized scientist who is committed to promote women to embrace scientific research careers, especially at the leadership level. She obtained prestigious and highly competitive funding and awards (Young investigator Chair, French Research Agency 2013-2017, European Research Council Starting Grant 2017-2022, Young investigator award International Conference of Human Genetics, Kyoto 2016). She has published over 56 original articles and reviews, including in high impact journals (e.g Science, Nature genetics, JACC), raised >2.3 Million€ through highly competitive funding schemes.
